We then introduced two mutations, Asn149Ser and Phe366Ala, to disrupt sodium and nucleoside binding of CNT NW , respectively 27 (Extended Data Fig. 2 ). We crystallized CNT NW N149S,F366A in the absence of sodium and nucleoside and collected data to a resolution of 3.45 Å (Extended Data Table 1 ). Two protomers (protomers A and B) adopted an inward-facing conformation that was nearly identical to that of wild-type CNT NW except for structural changes in HP1 (see below).
Secondary active transporters translocate substrates across the membrane against their concentration gradients by coupling to the movement of ions (typically Na + or H + ) down electrochemical gradients 1, 2 . A key element of this thermodynamically uphill process is the alternation of access to substrate-binding sites between the extracellular and intracellular sides of the membrane 3, 4 . Prevailing models for this alternating access are the rocker-switch and rocking bundle mechanisms, wherein the substrate-binding sites are fixed and the rocking motion of the protein domain(s) forms barriers above or below the substrate-binding sites in an alternating fashion [5] [6] [7] . Recently, the elevator model has emerged, wherein a mobile transport domain containing the substrate-binding sites moves as a rigid body along a static scaffold domain to achieve alternating access 5, 8, 9 . This mechanism was first proposed as a result of crystal structures of the aspartate transporter Glt Ph in inward-and outward-facing conformations 9, 10 , and further characterized by biophysical studies [11] [12] [13] [14] . Recent studies of sodium-coupled transporters have suggested that the elevator mechanism is more widely used than previously thought [15] [16] [17] [18] .
The elevator motion has been inferred as a single rigid-body transition mainly because crystal structures were available for only the two end states 9, 10, 16, 17 . This has led to many questions about the structural transition between the two end states. Is the motion composed of a single step or multiple steps? Does the transport domain move as a rigid body or does it undergo conformational changes? How do interactions between the transport and scaffold domains change while preventing non-specific ion leakage and hysteresis? Notably, single-molecule fluorescence resonance energy transfer (smFRET) and electron paramagnetic resonance (EPR) studies of Glt Ph have suggested that there is an intermediate step between the inward and outward states 13, 19 . However, without structural information for intermediate states, it is difficult to investigate the transitional steps of the mechanism. Here we present structures of a concentrative nucleoside transporter (CNT) in inward-substrate-bound, inwardopen, multiple intermediate, and outward-open conformations. Our findings provide many structural and mechanistic insights into the conformational pathway of the elevator transition of this secondary active transporter.
Uridine-bound inward-occluded conformation
CNTs use sodium or proton gradients to transport nucleosides for DNA and RNA synthesis [20] [21] [22] . Furthermore, they mediate cellular uptake of nucleoside-analogue drugs for the treatment of cancer and viral infection [23] [24] [25] . We previously determined structures of Vibrio cholerae CNT (vcCNT) in complex with nucleosides and nucleoside analogues in the presence of sodium, all of which adopted an inward-occluded conformation 26, 27 . Because vcCNT is resistant to crystallization in alternate conformations, we screened additional orthologues and identified a CNT from Neisseria wadsworthii (CNT NW ) that is stable in the absence of sodium and nucleoside (Extended Data Fig. 1 ). CNT NW mediates sodium-dependent nucleoside transport similar to that of vcCNT and binds uridine when solubilized in detergent (Extended Data Fig. 2 ). We first obtained the sodium-and uridine-bound structure of CNT NW , which adopts an inward-occluded conformation nearly identical to that of vcCNT (Cα root mean square deviation (r.m.s.d.) of 0.7 Å). The overall fold is composed of two domains: a transport domain, containing transmembrane helices (TM1, TM2, TM5 and TM8), helical hairpins (HP1 and HP2) and partially unwound helices (TM4 and TM7), and a scaffold domain, consisting of TM6 and TM3, that is involved in trimerization (Extended Data Fig. 2 ). The nucleosidebinding site is formed by HP1, HP2 and the unwound parts of TM4 and TM7, and the putative sodium-binding site is located between the tip of HP1 and the unwound portion of TM4. TM6 is speculated to serve as a hydrophobic barrier to nucleoside transport 26 . The nucleoside-binding site is located below TM6 where the top of the transport domain (TM4b and HP2b) interacts with the scaffold domain (TM3 and TM6), sealing off access to the extracellular space (Extended Data Fig. 2) . Surprisingly, the third protomer (protomer C) adopted a different conformation ( Fig. 1 ). In this conformation, only TM3 and TM6 are unchanged, while the remaining transmembrane helices move a large distance towards the extracellular side. The translocation of the transport domain involves an approximately 12 Å upward movement and an approximately 18° pivot with respect to the membrane plane. Unlike Glt Ph , the transport domain of CNT NW N149S,F366A does not twist appreciably relative to membrane normal. This movement places the sodium-and nucleoside-binding sites above TM6, making both sites accessible to the extracellular side. Therefore, we propose that this new conformation represents the outward-facing open state. Notably, the sodium-binding site is accessible to the extracellular side through a separate portal (Extended Data Fig. 3 ).
We crystallized an additional mutant, Asn149Ser/Glu332Ala (CNT NW N149S,E332A ), in which both binding sites were disrupted 27 . CNT NW N149S,E332A adopts a conformation similar to that of CNT NW N149S,F366A , suggesting that the outward-facing conformation is not unique to the particular mutation, but rather results from the shift in equilibrium towards the substrate-free state (Extended Data Fig. 3 ). There is substantial disparity between the positions of the transport domains in the outward-facing structure of CNT NW N149S,F366A and the previously proposed outward-facing homology model of vcCNT (Cα r.m.s.d 7.9 Å) 28 (Extended Data Fig. 3 ).
Intermediate conformations
We introduced the mutation Asn149Leu into CNT NW , which reduces affinity and flux for uridine more substantially than Asn149Ser (Extended Data Fig. 2 ). We obtained CNT NW N149L crystals in the absence of sodium and nucleoside that diffracted to 3.55-4.2 Å (Extended Data Table 1 and Extended Data Fig. 4 ). Similar to CNT NW N149S,F366A , protomers A and B adopt an inward-facing conformation that is nearly identical to the wild-type except for structural changes in HP1 (see below). In protomer C, however, the transport domain assumes a position that is strikingly different from both the inward-and outward-facing states (Fig. 2) . The transport domain is positioned about halfway between the end states, placing the substratebinding site behind TM6. Furthermore, we solved many structures of CNT NW N149L from different crystals and found that the location and conformation of the transport domain were slightly different in each structure and could be clustered into three groups (Extended Data Fig. 5 ). We refer to these crystals as CNT NW N149L -1 (intermediate 1), Table 1 ). Crystal packing explains why only protomer C shows different conformations, as the transport domains of protomers A and B are involved in packing interactions whereas protomer C is free to move (Extended Data Fig. 6 ).
When all the structures are aligned, HP1 of the transport domain moves about 6 Å from the inward-facing state to intermediate 1 and about 5 Å from intermediate 3 to the outward-facing state ( Fig. 2 and Supplementary Video 1).
Physiological relevance of the new conformations
We performed cross-linking experiments to test whether the new conformations are physiologically relevant. In a functionally competent Cys-less background (Cys364Ser), we introduced one cysteine mutation into the transport domain and another into the scaffold domain of the neighbouring protomer so that disulfide cross-linking would lead to a covalently linked trimer. We mutated residues that were within cross-linking distance only in one state but not the others ( Fig. 3 ). We found that disulfide cross-linking occurred spontaneously to some extent in isolated membranes for each cross-linking mutant (Extended Data Fig. 7 ). Cross-linking reached near completion upon addition of the oxidant copper phenanthroline (CuPhe) and could be reduced by treatment with dithiothreitol (DTT) ( Fig. 3 ). Detergent-solubilized mutants spontaneously cross-linked to near completion (Extended Data Fig. 7 ). The negative control (S109C, A373C), carrying mutations far from one another in all conformations, did not cross-link.
To functionally probe the new conformations, we reconstituted spontaneously cross-linked mutants into proteoliposomes (Extended Data Fig. 7 ) and performed uridine flux assays ( Fig. 3 ). We reasoned that if we locked the transporter in one state, it would not be able to transport nucleosides, but when reduced by DTT, it would regain transport activity. We found that the cross-linked mutants were nearly inactive, but when reduced the transport activity was restored substantially ( Fig. 3 ). As the cross-linking mutants did not include the mutations used for crystallization, we conclude that the newly observed conformations reflect physiologically relevant states.
State-dependent structural changes
During the elevator-like motion, the transport domain changes its interactions with the scaffold domain in a state-dependent manner. The interface is made up of HP1b, HP2b, TM4b and TM7b on the transport domain and TM3 and TM6 on the scaffold domain ( Fig. 4a and Extended Data Fig. 8 ). In the inward-facing state, TM4b and HP2b interact with the scaffold domain to close off the binding sites from the extracellular side. In the intermediate states, HP1b, HP2b, TM4b and TM7b interact with the scaffold domain, rendering both substrate-binding sites inaccessible to both sides of the membrane. Accordingly, a more extensive interface appears to be formed in these intermediates (~ 1,800 Å 2 ) than in the inward-facing (~ 1,400 Å 2 ) or outward-facing (~ 1,700 Å 2 ) states (Fig. 4a ). The interface is mainly composed of hydrophobic amino acids, except for Glu156 on HP1 (Extended Data Fig. 8 ). In the outward-facing conformation, HP1b and TM7b interact with the scaffold domain to shield the binding sites from the cytoplasm. In the intermediate states, the substrate-binding sites are occluded from both sides of the membrane, leaving no room for ions to leak through ( Fig. 4b) . Notably, the size of the nucleoside-binding site decreases gradually as the transport domain moves towards the middle intermediate state (intermediate 2) . This suggests that during the elevator transition, the transport domain becomes compact at the intermediate states and expands at the two end states. , HP1 from these protomers adopts conformations that are notably different from the inward-occluded substrate-bound state. The conformations of HP1 can be largely categorized into three groups ( Fig. 5 and Extended Data Fig. 9 ). The first group, from the substrate-bound conformation, finds HP1 close to the nucleoside as HP1b interacts with its nucleobase via water molecules, as shown in vcCNT 27 (Extended Data Fig. 2 ). In the second group, HP1b is rotated out by about 30° and moved about 6 Å compared to the substrate-bound conformation, positioning HP1b away from the nucleoside-binding site and exposing both binding sites to the cytoplasm. We believe that this represents an inward-open state. Overlays of protomers with similar HP1 conformations show different degrees of HP1b rotation, providing snapshots of the transition from the inward-occluded to the inward-open state (Extended Data Fig. 9 ). We found a third, less populated group with HP1b unwound and the tip of HP1 reaching towards Phe366, the centre of the nucleoside-binding site. We speculate that this conformation represents an inward-facing pre-translocation state. In the inward-open state, HP1b sticks out towards the cytoplasm below TM6 such that upward movement towards the outward-facing state would result in a steric clash. Therefore, after the nucleoside and sodium are released, a conformational rearrangement of HP1b, as seen in structural group 3, is necessary to progress through the transport cycle. Thus, HP1 serves as an intracellular gate by changing its conformation at HP1b (Supplementary Video 1).
The roles of HP1b and TM4b as gates
In the intermediate and outward-facing states, HP1 assumes conformations similar to that of the inward-facing substrate-bound state. The minor change is that HP1b rotates and moves up towards the nucleoside-binding site owing to the interaction between Gln154 on HP1b and Ser371 on TM7b, two residues involved in nucleoside binding (Extended Data Fig. 3 ). In the intermediate states, TM4b is pushed down towards the nucleoside-binding site compared to the two end states (Fig. 5 ). These rearrangements of HP1 and TM4b make the transport domain more compact in the intermediate states, rendering the hydrophilic nucleoside-binding site smaller and inaccessible to either side of the membrane (Figs 4b, 5g and Extended Data Fig. 8 ). Notably, from intermediate 3 to the outward-facing conformation, TM4b moves up and away from the nucleoside-binding site by about 5 Å (Fig. 5g ). This motion not only renders the nucleoside-binding site accessible to the extracellular side but also leads to the creation of an extracellular portal to the sodium-binding site (Extended Data Fig. 3 ). We therefore suggest that TM4b serves as an extracellular gate.
Discussion
Our structures of CNT NW represent the inward-occluded (substratebound), inward-open, inward-pre-translocation, intermediate, and outward-open states, illustrating the conformational pathway between the two end states ( Fig. 6 and Supplementary Video 1). Previously, a structure of Glt Ph representing an inward-facing 'unlocked' state was reported in which the interactions between the transport and scaffold domains were loosened 12 . However, our intermediate states are distinct in that the transport domain moves halfway through the membrane. These intermediate structures provide new insights into the elevator mechanism, suggesting that the elevator motion involves intermediate steps rather than a single rigid-body motion. Why do these intermediate states exist? They might guide the conformational path of the repetitive large-scale motions of the transport domain and thus prevent hysteresis and non-specific ion leakage. Consistent with this idea, in the intermediate states, the transport domain is more compact and its hydrophilic nucleoside-binding site is occluded by interactions with the TM3   TM3  TM3  TM3   TM7b  TM7b  TM7b  TM7b   HP1b  HP1b   HP1b   HP1b   TM3   TM6   TM4b   HP2   TM7b   TM3   TM6   TM4b HP2 TM7b scaffold domain. Another possibility is that these intermediate states serve as a barrier for the transition between the end states. Interestingly, smFRET studies of Glt Ph showed that the transport domain visits an intermediate step that serves as a barrier between the end states 13 . Without these intermediates, uninterrupted switching between the end states in the absence of nucleoside would result in sodium leakage 13 . Consistent with this idea, the interactions between the transport and the scaffold domains are most extensive in the intermediate states of CNT NW . It is noteworthy that mutation of the glutamate residue on HP1 in human CNT1 and CNT3 (Glu321 in hCNT1 and Glu343 in hCNT3) leads to nucleoside-uncoupled sodium leak currents 29, 30 . The corresponding residue in CNT NW (Glu156) is the only charged residue located at the domain interface in the intermediate states (Extended Data Fig. 8 ).
Our structural observations of the intermediate states in the absence of substrates leads us to ask whether similar states exist when the transporter is bound to sodium and nucleoside. If these states exist, the nucleoside-binding site must adopt different conformations to accommodate nucleosides, as nucleoside cannot be bound in the compacted transport domain of the substrate-free intermediate states (Fig. 4) .
Our new structures also show that different gates (HP1b and TM4b) are responsible for each end state. While HP1b serves as a gate in the inward-facing state, it remains largely unchanged in the other states. TM4b changes its conformation in each state. In particular, TM4b plays a major role in making the transport domain more compact in the intermediate states. In short, our structural work suggests that the transport domain undergoes state-dependent conformational changes rather than a single rigid-body motion during its elevator-like movement.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. article reSearcH structures were aligned on protomers A and B to visualize and quantify the movement of protomer C. The side chains of certain residues in the interface between the transport and scaffold domain and binding site cavity were not supported by electron density. Therefore, these residues were truncated to the Cβ position in the deposited coordinates. However, to provide a more reliable representation of the interactions, the side chains of these residues, built as the most likely rotamer, were included for the analysis of the interface and binding site. The buried surface area was calculated in PyMOL with a high sampling density (dot_density 3) using the following equation: ((solvent accessible surface area of the transport domain alone) + (solvent accessible surface area of TM3 and TM6)) − (solvent-accessible surface area of the transport domain, TM3, and TM6 together). The binding site cavity was created by selection of cavity-lining residues shown in surface cavity mode in PyMOL 40 and clipped for clarity. Anomalous difference Fourier maps of the SeMet-substituted and Se marker mutants were calculated using MR phases of two protomers (A and B) , excluding protomer C. Single wavelength anomalous dispersion phases of CNT NW N149L -3 were calculated using these Se sites from anomalous difference Fourier maps followed by solvent flattening using AutoSol 38 . Isothermal titration calorimetry. DMNG-solubilized CNT NW protein, purified in the absence or presence of sodium, was concentrated to 25 μ M. Uridine (3 mM) was titrated into the protein solution 4 μ l at a time using a MicroCal VP-ITC system. For ITC experiments with CNT NW N149L , 12 mM uridine was titrated 2 μ l at a time into an 80-μ M protein solution using a MicroCal ITC200 system. The data were fit to a single-site binding isotherm. Vesicle reconstitution and flux assay. Protein purified in DM was reconstituted into lipid vesicles as described previously 41 . Briefly, lipid vesicles were prepared consisting of 10 mg ml −1 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) in a 3:1 POPE:POPG ratio. Protein was reconstituted in the lipid vesicles at a 1:500 protein to lipid mass ratio. The vesicles contained 20 mM HEPES pH 7.4, 200 mM KCl, and 100 mM choline chloride (ChCl). Vesicles were flash-frozen in liquid nitrogen and stored at − 80 °C until further use.
For flux experiments, vesicles were thawed and frozen three times before extrusion through a 1-μ m filter. For flux assay experiments with the cysteine cross-linking mutants, the vesicles were incubated with or without 10 mM DTT at 37 °C for 10 min before extrusion. The vesicles were diluted 20 times into flux assay buffer (20 mM HEPES pH 7.4, 100 mM KCl, and 200 mM ChCl or NaCl). The flux assay was performed with 2 μ M radioactively labelled uridine and 1 μ M valinomycin at 30 °C for 5 min. Vesicles were harvested on GF/B glass microfibre filters and counted by scintillation. Cross-linking experiments. Cross-linking mutants of CNT NW were prepared in a Cys-less background. The following mutants were cloned by QuikChange mutagenesis: Cys-less mutant CNT NW C364S , negative control CNT NW S109C,C364S,A373C , inward-facing cross-linking mutant CNT NW T243C,C364S,A373C , intermediate cross-linking mutant CNT NW E240C,C364S,R387C , and outward-facing cross-linking mutant CNT NW T243C,C364S,K388C . For membrane cross-linking experiments, protein was expressed for 1 h at 37 °C and cells were collected by centrifugation. Cells were lysed by sonication and lysate was spun down twice at 6,660g for 15 min at 4 °C, followed by a high-speed spin (120,000g for 1 h) of the supernatant to pellet the membrane fraction. The membrane was resuspended in assay buffer (20 mM Tris pH 8.0, 150 mM NaCl). The crude membrane was sonicated twice for 1 min each in a water bath sonicator and incubated for 20 min at room temperature with 20 μ M copper phenantroline or 10 mM DTT. The cross-linking reaction was quenched by addition of 20 μ M N-ethylmaleimide and 50 mM EDTA. Loading buffer with 4% sodium dodecyl sulphate and 4 M urea was added to the samples. The samples were incubated at 60 °C for 10 min before loading onto an SDS-PAGE gel for western blot analysis using an anti-histidine tag primary antibody (Sigma-Aldrich catalogue number H1029; antibody-validation information is available at http://www.sigmaaldrich.com/catalog/product/sigma/h1029?lang= en&region= US) and an anti-mouse secondary antibody (Licor catalogue number 926-32212; antibody-validation information is available at https://www.licor.com/documents/ x8h1udxje8ker0tcaf8q7utpleagu4tv). For gel source data, see Supplementary Fig. 1 . For proteoliposome reconstitution, cross-linking mutants were prepared in the same way as liposomes with wild-type protein. ).
MethOdS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Expression and purification. CNT NW was expressed from a modified pET26 vector containing a pelB leader sequence and an N-terminal PreScission protease cleavable His 10 -maltose-binding-protein tag, as described previously for vcCNT 26 . Protein was expressed in Escherichia coli C41(DE3) cells for 4 h at 37 °C. SeMetlabelled protein was expressed in E. coli C41(DE3) cells grown in M9 medium supplemented with 100 mg ml −1 lysine, phenylalanine, and threonine; 50 mg ml −1 isoleucine, leucine, and valine; and 60 mg ml −1 SeMet at time of induction 31 . After expression, SeMet-labelled protein was purified in the same way as non-labelled protein. Cells were lysed by sonication and membrane proteins were extracted from the lysate in 30 mM dodecyl maltoside. The insoluble fraction was removed by centrifugation and CNT was purified from the supernatant by Co 2+ -affinity chromatography. Protein was digested overnight with PreScission protease. The protein was exchanged to decyl maltoside neopentyl glycol (DMNG) for crystallization and isothermal titration calorimetry experiments or decyl maltoside (DM) for proteoliposome preparation by concentration and subsequent dilution in the new detergent. The sample was applied to a Superdex 200 size-exclusion column pre-equilibrated with 20 mM Tris pH 8, 150 mM NaCl, 2 mM DTT, and 4 mM DM or 0.5 mM DMNG. For crystallization and ITC experiments in the absence of sodium, sodium was removed from the purification in the wash step of affinity chromatography and subsequent buffers contained 150 mM KCl instead of NaCl. For cross-linking experiments, protein was purified in the absence of DTT. Crystallization. The protein was concentrated to ~ 10 mg ml −1 and mixed with the crystallization solution at a 1:1 ratio in 24-well sitting drop trays. Crystals grew in a wide range of conditions, but crystals grown in the following conditions were used in structure determination. The structure of wild-type CNT NW was solved from crystals grown in 1 M NaCl, 35% PEG400, pH 9.5; CNT NW , solutions for protomers A and B were found using wild-type CNT NW as a search model. As for protomer C, transport and scaffold domains were used as separate search models after observing a substantial domain movement. The connecting regions between the domains such as interfacial helices were built manually during refinement. Coot 37 and PHENIX 38 were used to refine the structures. Refinement of protomers A and B was restrained by non-crystallographic symmetry (NCS) and reference model (wild-type CNT NW ) until near convergence. Protomer C was refined using secondary structure restraints generated from wild-type CNT NW . Manual refinement of protomer C was performed initially only by rigid-body fitting of whole domains. The sizes of the rigid bodies were gradually decreased to individual helices as the electron density map improved. Only when the main chain location was accurately determined were the side chain positions refined. To determine the conformation of HP1 in each structure, omit maps were generated and HP1 was rebuilt manually into positive density. Near convergence the NCS and reference model restraints were released. Each structure was analysed using MolProbity 39 and further refined to minimize clashes and optimize geometry. The . Experiments were performed in triplicate (technical replicates). c, CNT NW trimer viewed from the intracellular side (left) and within the membrane plane (right). d, CNT NW viewed from the trimerization axis, coloured as in Fig. 1 , with uridine in yellow and sodium in green. e, CNT topology diagram, coloured as in Fig. 1. f, g, Detailed view of the nucleoside-binding sites for CNT NW (f) and vcCNT (g). The configuration of the binding sites is nearly identical, except for Glu156 which adopts a different rotamer conformation in CNT NW .
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Extended Data Figure 3 | Quality of the structure and electron density of the outward-facing structure. a, 2F o − F c simulated annealing (SA) composite omit map, calculated using 3,000 K, is shown at 1σ for the outward-facing protomer region in the CNT NW N149S,F366A crystal structure. The model is shown in ribbon representation with side chains in line representation where supported by the density, coloured as in Fig. 1. b , Cutout surface and cartoon representation of the outwardfacing conformation, coloured as in Fig. 1 . Two separate paths, outlined in yellow, provide access to either the sodium-or nucleoside-binding pockets. c, Cartoon representation of the crystal structures of two sodium-and nucleoside-binding mutants, CNT NW N149S,F366A (blue) and CNT NW N149S,E332A (green). The structures overlay with an overall Cα r.m.s.d. of 0.5 Å. CNT NW trimer viewed from within the membrane plane. The asterisk denotes the outward-facing protomer. d, Comparison of the outward-facing crystal structure (blue) with the repeat-swap-modelled outward-facing conformation (red, Protein Model DataBase PM0080188). In the crystal structure Phe366 (blue circle) was found to be 9 Å closer to the extracellular side of the membrane than in the modelled structure (red circle). The Cα r.m.s.d. of the transport domain alone is 7.9 Å, showing a substantial difference between the two structures.

Extended Data Figure 4 | Experimentally phased map of CNT NW N149L -3 and anomalous signals from SeMet-labelled CNT NW N149L -1 and CNT NW
N149L -3 guided model building. a, b, An overview (a) and detailed view (b) of the electron density map of CNT NW N149L -3, solved by single anomalous dispersion phasing followed by solvent flattening at 3.55 Å. The experimentally phased map is shown in blue mesh at 1σ and the model is shown in ribbon representation with side chains as sticks where supported by the density, coloured as in Fig. 1 . The asterisk denotes the outwardfacing protomer. c, d, Anomalous difference Fourier maps were calculated using the MR phases of protomers A and B of CNT NW N149L -1 at 6 Å (c) and for CNT NW N149L -3 at 3.6 Å (d) (blue mesh at 3.5σ). Two mutants were designed to carry an additional methionine in HP1, CNT NW Fig. 1 . b, Interactions between TM3 (grey) and transport domain elements TM4b (orange) and HP1b (red), coloured as in Fig. 1 . The black box indicates the region shown in c. c, On the basis of its Cα location, Glu156, the only charged residue on the transport domain at this interface, appears to be positioned towards the interface with the scaffold domain in the intermediate states. The side chain is modelled as its ideal rotamer and a 2F o − F c SA composite omit electron density map (blue mesh, 0.8σ) is shown. d, Cutout surface depictions show the changes in the specific interactions between TM6 and the transport domain elements HP2b and TM7b during the elevator motion. The interaction network is mostly made up of hydrophobic interactions. 
